CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 4/A Grant or award Director acquired 35,360 shares (grant or award)
- 4 Grant or award Director acquired 35,360 shares (grant or award)
- 4 Grant or award Director acquired 35,360 shares (grant or award)
- 4 Grant or award Director acquired 35,360 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Grant or award Director acquired 5,890 shares (grant or award)
- 4 Grant or award Director acquired 3,122 shares (grant or award)
- 4 Grant or award Director acquired 2,945 shares (grant or award)
- 4 Grant or award Director acquired 647 shares (grant or award)
- 4 Shares withheld for taxes SVP, Controller & CAO gave up 3,188 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 116,982 shares (to pay taxes)
- 4 Planned sale EVP, General Counsel sold 6,313 shares at $9.80 ($61,867)
- 144 Insider Sale of Securities
- 10-K Report Annual Report
Page 11 of 121 · 2,419 filings